• A once-daily Wegovy weight loss pill is now available to buy privately from UK high street and online pharmacies.
  • The tablet contains semaglutide, the same active ingredient used in Wegovy injections, but it is not yet available on the NHS.
  • Experts say the pill could be a useful option for people who do not want injections, but it still needs to be used alongside healthy eating, physical activity and medical supervision.

A tablet version of Wegovy has launched privately in the UK, giving people another way to access semaglutide-based weight loss treatment.

The pill is taken once a day and is the first oral GLP-1 weight loss medicine approved in the UK. The Medicines and Healthcare products Regulatory Agency approved the new tablet form on 11 June 2026.

Like the Wegovy injection, the pill works by mimicking GLP-1, a hormone involved in appetite regulation. It can help people feel fuller, reduce hunger and lower cravings.

However, it is not a quick fix. Wegovy should be used alongside a reduced-calorie diet, increased physical activity and ongoing clinical support.

Who can use the Wegovy pill?

The Wegovy pill is intended for adults living with obesity or overweight who meet clinical eligibility criteria.

It may be prescribed privately to people with a BMI of 30 or above, or to people with a BMI between 27 and 30 if they also have at least one weight-related health condition, such as type 2 diabetes, high blood pressure or obstructive sleep apnoea.

A consultation is required before treatment starts. This may be completed online or face-to-face, depending on the pharmacy or provider.

The medicine should not be used by people under 18, or by those who are pregnant or breastfeeding.

Anyone with existing medical conditions or taking other medication should speak to a healthcare professional before starting treatment.

How is the pill taken?

The tablet has strict instructions because food, drink and other medicines can affect how well it is absorbed.

It should be taken after fasting for at least eight hours, with a small sip of plain water. People are then advised to wait at least 30 minutes before eating, drinking anything else or taking other tablets.

That means it may suit people who already have a regular morning routine, but it may be less convenient for those who struggle with fasting or need to take other medicines early in the day.

If a dose is missed, the usual advice is to skip that day’s tablet and take the next scheduled dose the following day.

Wegovy pill vs Wegovy injection

The main difference is how the medicine is taken.

The injection is taken once a week, while the pill is taken every day.

The injection also needs fridge storage, whereas the tablet may be more convenient for some people.

For people who dislike needles, the tablet may feel like a more acceptable option.

For others, a weekly injection may be easier than remembering a daily tablet with fasting instructions.

The best choice will depend on medical history, lifestyle, treatment goals and personal preference.

What dose do people start on?

Treatment usually starts at a low dose and increases gradually.

The tablet strengths approved in Europe are 1.5mg, 4mg, 9mg and 25mg.

The dose is increased over time to help the body adjust and reduce side effects.

People should not try to switch between Wegovy injections and tablets without clinical advice.

The dosing is not a simple like-for-like swap, so any change should be supervised by a healthcare professional.

How well does it work?

Clinical trial data suggest that oral semaglutide can support significant weight loss when used alongside diet and physical activity.

In a 64-week trial, people taking Wegovy tablets lost an average of 13.61% of their body weight, compared with 2.18% among people taking a placebo.

The results are promising, but they also underline an important point: the medication was tested as part of a wider treatment plan, not as a standalone solution.

Weight regain can also happen after stopping GLP-1 medication, which is why long-term lifestyle support remains important.

What are the side effects?

The most common side effects are gastrointestinal. These can include nausea, vomiting, constipation, diarrhoea and stomach pain.

Some people may also experience headaches or tiredness.

More serious side effects are less common but can include pancreatitis, severe allergic reactions and low blood sugar, particularly in people taking other medicines that affect blood glucose.

Anyone taking Wegovy should read the patient information leaflet and report concerning symptoms to a healthcare professional.

Is the Wegovy pill available on the NHS?

Not currently.

Although the tablet has been approved by the MHRA, it has not yet been recommended for NHS use.

NICE would need to review the clinical and cost-effectiveness evidence before it could be made available through NHS pathways.

NICE already has guidance for injectable semaglutide for weight management, but the tablet form will need to be considered separately if it is to be used on the NHS.

How much does it cost privately?

Private prices vary by pharmacy, dose and introductory offers.

Some providers are pricing lower starting doses at around £99 per month, while higher doses may cost closer to £199 per month.

Prices may change as supply, demand and competition develop.

Patients should be cautious about very cheap offers, social media sellers or websites that do not require a consultation.

What about counterfeit medicines?

The growing demand for GLP-1 treatments has increased concern about counterfeit products.

People should only buy Wegovy from regulated pharmacies and should avoid sellers offering the medicine without a prescription or clinical assessment.

Fake weight loss medicines can contain incorrect doses, unknown ingredients or harmful substances. Anyone unsure about a product should check with a pharmacist or healthcare professional before taking it.

Is this a turning point for weight loss treatment?

The arrival of an oral GLP-1 option is a major development because it gives patients more choice.

For some people, a tablet may reduce the barrier to starting treatment.

For others, the daily fasting routine may make the weekly injection more practical.

Either way, the same rule applies: Wegovy is a medical treatment for obesity and weight-related health conditions, not a cosmetic shortcut.

Its safest and most effective use is as part of a structured plan that includes nutrition, movement, behaviour change and ongoing clinical oversight.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.